HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 92 filers reported holding HARVARD BIOSCIENCE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $78,084 | +59.5% | 18,159 | +103.6% | 0.00% | – |
Q2 2023 | $48,959 | -67.7% | 8,918 | -75.3% | 0.00% | – |
Q1 2023 | $151,717 | +517.1% | 36,123 | +307.0% | 0.00% | – |
Q4 2022 | $24,584 | +11.7% | 8,875 | +4.0% | 0.00% | – |
Q3 2022 | $22,000 | +633.3% | 8,533 | +725.2% | 0.00% | – |
Q2 2022 | $3,000 | -98.1% | 1,034 | -96.0% | 0.00% | – |
Q1 2022 | $160,000 | +28.0% | 25,755 | +44.9% | 0.00% | – |
Q4 2021 | $125,000 | +145.1% | 17,779 | +144.7% | 0.00% | – |
Q3 2021 | $51,000 | -13.6% | 7,267 | +2.7% | 0.00% | – |
Q2 2021 | $59,000 | -76.9% | 7,076 | -84.9% | 0.00% | – |
Q1 2021 | $255,000 | +325.0% | 46,753 | +234.2% | 0.00% | – |
Q4 2020 | $60,000 | +1100.0% | 13,989 | +754.0% | 0.00% | – |
Q3 2020 | $5,000 | -79.2% | 1,638 | -78.3% | 0.00% | – |
Q2 2020 | $24,000 | +2300.0% | 7,535 | +2386.8% | 0.00% | – |
Q3 2019 | $1,000 | -99.3% | 303 | -99.6% | 0.00% | – |
Q2 2019 | $136,000 | -93.6% | 68,164 | -86.1% | 0.00% | – |
Q1 2019 | $2,120,000 | +709.2% | 491,774 | +495.1% | 0.00% | – |
Q4 2018 | $262,000 | -35.0% | 82,642 | +7.6% | 0.00% | – |
Q3 2018 | $403,000 | -48.8% | 76,807 | -47.8% | 0.00% | – |
Q2 2018 | $787,000 | +6.4% | 147,066 | -0.6% | 0.00% | – |
Q1 2018 | $740,000 | +58.5% | 147,977 | +4.7% | 0.00% | – |
Q4 2017 | $467,000 | -11.9% | 141,393 | 0.0% | 0.00% | – |
Q3 2017 | $530,000 | +46.8% | 141,393 | 0.0% | 0.00% | – |
Q2 2017 | $361,000 | +38.8% | 141,393 | +41.5% | 0.00% | – |
Q1 2017 | $260,000 | -14.8% | 99,911 | -0.2% | 0.00% | – |
Q4 2016 | $305,000 | +12.1% | 100,082 | +0.1% | 0.00% | – |
Q3 2016 | $272,000 | -16.0% | 99,950 | -11.8% | 0.00% | – |
Q2 2016 | $324,000 | +7.3% | 113,292 | +13.4% | 0.00% | – |
Q1 2016 | $302,000 | -14.2% | 99,908 | -1.8% | 0.00% | – |
Q4 2015 | $352,000 | +17500.0% | 101,717 | +18063.8% | 0.00% | – |
Q3 2015 | $2,000 | -81.8% | 560 | -72.1% | 0.00% | – |
Q2 2015 | $11,000 | -96.2% | 2,006 | -96.9% | 0.00% | – |
Q2 2014 | $293,000 | – | 64,386 | +121383.0% | 0.00% | – |
Q1 2014 | $0 | -100.0% | 53 | -73.5% | 0.00% | – |
Q4 2013 | $1,000 | -87.5% | 200 | -86.5% | 0.00% | – |
Q3 2013 | $8,000 | -87.9% | 1,478 | -89.6% | 0.00% | – |
Q2 2013 | $66,000 | – | 14,148 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 1,020,036 | $7,120,000 | 5.32% |
Portolan Capital Management | 2,358,010 | $16,459,000 | 1.20% |
Acuitas Investments, LLC | 375,836 | $2,623,000 | 1.14% |
Parkman Healthcare Partners LLC | 475,367 | $3,318,000 | 0.84% |
Adirondack Research & Management Inc. | 90,020 | $628,000 | 0.76% |
Archon Capital Management LLC | 736,236 | $5,139,000 | 0.73% |
BARD ASSOCIATES INC | 294,697 | $2,057,000 | 0.70% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,621,775 | $11,320,000 | 0.65% |
GLOBEFLEX CAPITAL L P | 268,466 | $1,874,000 | 0.41% |
Monarch Partners Asset Management LLC | 330,083 | $2,304,000 | 0.34% |